The Latest
Letters to OfficialsCCAGW Urges House Oversight Committee to Oppose H.R. 6283
H.R. 6283 would impose unnecessary and harmful regulations on PBMs that will lead to higher prices and fewer options.
State ActionCCAGW Urges Virginia Senators to Oppose Senate Bill 274
SB 274 which would impose price controls on prescription drugs.
State ActionCCAGW Urges Indiana Legislators to Oppose Senate Bill 3
SB3 would ban PBMs from utilizing formularies to reduce patient costs.
State ActionCCAGW Urges West Virginia Legislators to Oppose Senate Bill 325
SB 325 would change how the federal 340B program operates in the Mountain State.
Press ReleaseCitizens Against Government Waste Names Sen. Ed Markey and Rep. Alexandria Ocasio-Cortez 2023 Porker of the Year
The dishonor went to Sen. Markey and Rep. AOC for wanting to spend trillions of dollars for their latest GND scheme.
State ActionCCAGW Urges Kentucky Legislators to Oppose Senate Bill 27
SB 27 would change how the federal 340B program operates in the Commonwealth of Kentucky.
The WasteWatcherReflecting on Privacy Laws During Data Privacy Week
Data Privacy Week is an opportunity to review can be done to protect data and learn what privacy laws are being proposed.
The WasteWatcherIRS Errs in Moving its Own Tax Preparation System Forward
The Direct File program is another step in the IRS expanding its authority.
State ActionCCAGW Urges Missouri Legislators to Support House Bill 2057
HB 2057 would clarify that municipalities may not impose franchise fees on online streaming services.
Letters to OfficialsCCAGW Urges West Virginia Legislators to Oppose Senate Bill 325
SB 325 would make changes to the federal 340B drug discount program.
Press ReleaseCitizens Against Government Waste Names Gov. Glenn Youngkin January 2024 Porker of the Month
Gov. Youngkin has agreed to spend hundreds of millions of taxpayer dollars on a new mega sports complex.
Letters to OfficialsCCAGW Urges Florida Legislators to Oppose House Bill 1431
This legislation threatens drug innovation and development in the U.S. and will lead to fewer future cures.
